The Texas Institute of Dermatology Team Finds Easy-to-Apply, Topical Drug Just as Good as Injectable Compound for a Disfigurating Skin Infection
SAN ANTONIO, March 05, 2009 /PRNewswire/ -- A plentiful, inexpensive, topical compound is as effective at treating the skin lesions of Middle Eastern and African leishmaniasis as is the standard therapy, a less-available, costlier compound injected into lesions. That's one of the findings of a research team from , , and led by Reza F. Ghohestani, M.D., Ph.D., director of the Texas Institute of Dermatology and an associate professor of medicine at The Health Science Center at San Antonio.
The panel, reporting in the prestigious peer-reviewed journal , analyzed 14 major clinical research trials that enrolled 1,221 patients. The trials compared the standard therapeutics, known as pentavalent antimony compounds, with the topical treatment, paramomycin. Old World leishmaniasis infection is caused by parasites carried by the desert sandfly and can be found mainly in the Middle East, Mediterranean Sea coastal areas, Africa, and Asia.
More than 12 million people in 88 countries suffer from leishmaniasis and 2 million new cases are diagnosed annually, the authors wrote.
"Millions of people worldwide suffer with leishmaniasis, but we in South Texas should keep in mind that cutaneous leishmaniasis is not a rare entity here, either," Dr. Ghohestani said. "In our area the infection is mainly seen in people coming from Mexico and soldiers returning from Iraq."
Pentavalent antimony compounds were considered the main therapeutic option for all types of cutaneous leishmaniasis for decades. They were given intravenously, into muscle or into lesions.
"Our findings suggest that the topical paramomycin can be a good alternative for the Old World type of leishmaniasis, especially if MBCL is added," Dr. Ghohestani said. "Our group is now focused on improving delivery of paramomycin to the skin." The team is working with the Eastern Mediterranean regional office of the World Health Organization on this project.
The Texas Institute of Dermatology is the sole dermatology program in South Texas that combines basic and clinic research with clinical care. The Institute offers excellence in clinical dermatology as well as in basic and clinical research. General dermatology services are available for Skin Disorders. For more information, visit www.txdi.org or call 1-888-884-5557 Ext 2.
CONTACT: Maria E. Guerra of Texas Institute of Dermatology, 1-888-884-5557, Ext. 2, TexasDermatologyInstitute@gmail.com
Web site: http://www.txdi.org/
Terms and conditions of use apply
Copyright © 2009 PR Newswire Association LLC. All rights reserved.
A United Business Media Company
